|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 152.25 USD | +1.78% |
|
+15.53% | +7.35% |
| 07/05 | Deutsche Bank Adjusts Neurocrine Biosciences Price Target to $155 From $150, Maintains Hold Rating | MT |
| 06/05 | Neurocrine Posts Strong Q1 as Key Treatments Drive Growth, Morgan Stanley Says | MT |
| Capitalization | 1.53TCr 1.3TCr 1.19TCr 1.12TCr 2.1TCr 1,44600Cr 2.11TCr 14TCr 5.5TCr 69TCr 5.74TCr 5.62TCr 2,39800Cr | P/E ratio 2026 * |
30x | P/E ratio 2027 * | 14.2x |
|---|---|---|---|---|---|
| Enterprise value | 1.46TCr 1.24TCr 1.13TCr 1.07TCr 2TCr 1,37800Cr 2.01TCr 13TCr 5.25TCr 66TCr 5.47TCr 5.36TCr 2,28500Cr | EV / Sales 2026 * |
3.88x | EV / Sales 2027 * | 2.95x |
| Free-Float |
98.57% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Neurocrine Biosciences, Inc.
| 1 day | +1.78% | ||
| 1 week | +15.53% | ||
| Current month | +15.63% | ||
| 1 month | +15.66% | ||
| 3 months | +9.09% | ||
| 6 months | -0.08% | ||
| Current year | +7.35% |
| 1 week | 131.78 |  | 154.74 |
| 1 month | 125.64 | | 154.74 |
| Current year | 122.14 | | 154.74 |
| 1 year | 116 | | 160.18 |
| 3 years | 84.23 | | 160.18 |
| 5 years | 71.88 | | 160.18 |
| 10 years | 37.34 | | 160.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kyle Gano
CEO | Chief Executive Officer | 53 | 11/10/2024 |
| Director of Finance/CFO | 47 | 01/11/2017 | |
Lewis Choi
CTO | Chief Tech/Sci/R&D Officer | - | 09/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Gorman
BRD | Director/Board Member | 68 | 01/01/2008 |
Richard Pops
BRD | Director/Board Member | 64 | 01/04/1998 |
| Chairman | 78 | 01/05/2011 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.78% | +15.53% | +31.58% | +56.57% | 1.53TCr | |
| -2.72% | -1.54% | +29.12% | +121.40% | 85TCr | |
| -0.53% | -2.58% | +43.51% | +37.42% | 53TCr | |
| -0.57% | -2.44% | +9.18% | +37.27% | 36TCr | |
| -0.94% | -0.97% | +22.40% | +11.18% | 32TCr | |
| +0.23% | -1.24% | +30.31% | +12.00% | 28TCr | |
| +0.05% | -2.19% | +24.69% | +21.29% | 28TCr | |
| -0.82% | -0.70% | +46.61% | -5.15% | 28TCr | |
| -1.76% | +4.42% | -34.66% | -49.15% | 20TCr | |
| +0.79% | +0.57% | +24.76% | +41.49% | 18TCr | |
| Average | -0.45% | +0.88% | +22.75% | +28.43% | 32.91TCr | |
| Weighted average by Cap. | -1.04% | -1.19% | +25.66% | +44.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 376.16Cr 319.59Cr 292.48Cr 276.06Cr 514.94Cr 36TCr 519.48Cr 3.47TCr 1.35TCr 17TCr 1.41TCr 1.38TCr 59TCr | 450.22Cr 382.51Cr 350.06Cr 330.41Cr 616.32Cr 43TCr 621.76Cr 4.15TCr 1.62TCr 20TCr 1.69TCr 1.65TCr 71TCr |
| Net income | 47Cr 40Cr 37Cr 35Cr 65Cr 4.48TCr 65Cr 437.41Cr 170.51Cr 2.15TCr 177.92Cr 174.18Cr 7.43TCr | 110.68Cr 94Cr 86Cr 81Cr 151.52Cr 10TCr 152.85Cr 1.02TCr 397.95Cr 5.02TCr 415.25Cr 406.52Cr 17TCr |
| Net Debt | -72Cr -61Cr -56Cr -53Cr -98Cr -6.79TCr -99Cr -662.97Cr -258.44Cr -3.26TCr -269.68Cr -264.01Cr -11TCr | -200.62Cr -170.45Cr -155.99Cr -147.23Cr -274.64Cr -19TCr -277.06Cr -1.85TCr -721.32Cr -9.1TCr -752.68Cr -736.85Cr -31TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | 152.25 $ | +1.78% | 14,14,990 |
| 07/26/07 | 149.59 $ | +1.75% | 17,90,205 |
| 06/26/06 | 147.02 $ | +8.86% | 24,37,274 |
| 05/26/05 | 135.06 $ | +0.74% | 14,27,489 |
| 04/26/04 | 134.07 $ | +1.74% | 11,96,434 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NBIX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition